Systolic hypertension as a CV risk factor - Has it finally been accepted?

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 595-597

  Dustan, Harriet P ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; HISTORY; HUMAN; HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HISTORY, 20TH CENTURY; HUMANS; HYPERTENSION;

EID: 0033093377     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic pressure and risk of coronary heart disease, The Framingham Study. Amer J Cardiol 1971;27:335-46.
2. Mann SJ. Systolic hypertension in the elderly, pathophysiology and management. Arch Intern Med 1992;152:1977-84.
3. Fisher CM. The ascendancy of diastolic pressure over systolic. Lancet 1985;2:1349-50.
4. Janeway TC. A clinical study of hypertensive cardiovascular disease. Arch Intern Med 1913;12:755-98.
5. Society of Actuaries: Blood Pressure: Report of the Joint Committee on Mortality of the Association of Life Insurance Medical Directors and the Actuarial Society of America. New York, NY, Society of Actuaries; 1925.
6. Society of Actuaries. Blood Pressure Study 1939, New York, NY: Society of Actuaries and Association of Life Insurance Medical Directors; 1940.
7. Perry HM, Jr., Schroeder HA. Effect of treatment on mortality ratio in severe hypertension. Arch Intern Med 1958;102:418-25.
8. Dustan HP, Schneckloth RE, Corcoran AC, Page IH. The effectiveness of the long term treatment of malignant hypertension. Circulation 1958;18:644-51.
9. Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Effects of treatment or morbidity in hypertension, I: results in patients with diastolic pressures averaging 115 through 129 mmHg. JAMA 1967;202:1028-34.
10. Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-52.
11. Fineberg MH. Systolic hypertension; its relationship to atherosclerosis of aorta and large arteries. Amer J Med Sci 1927;173:835-43.
12. Gubner RS. Systolic hypertension: a pathogenetic entity. Amer J Cardiol 1962;9:773-6.
13. Build and Blood Pressure Study, Vol 1. Chicago, IL Society of Actuaries 1959, p 158.
14. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension, the Framingham Study. Circulation 1980;61:1179-82.
15. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988;77:504-14.
16. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
17. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
18. Breckenridge MB, Kostis JB. Isolated systolic hypertension in the elderly: results of a statewide survey of clinical practice in New Jersey. Am J Med 1989;86:370-5.